Ars Pharmaceuticals is expanding its $199 neffy retail access program while awaiting a crucial decision from CVS Caremark, aiming to boost affordability...
Retirees seeking income can find compelling opportunities in the healthcare sector. Three dividend-paying stocks—Pfizer, Medtronic, and Omega Healthcare—offer yields up to 6.5%...
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...
Pfizer shares have fallen over 50% from their 2021 high, leading many to label it "dead money." However, a closer look reveals...
Quantum BioPharma Ltd. has engaged Senergy Communications Capital Inc. and King Tide Media LLC for a one-month contract to bolster investor awareness...
Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, aiming to expand its cancer pipeline, The Wall...
Bristol Myers Squibb (BMY) shows compelling value with a low forward P/E and a 4.2% dividend yield, despite concerns over legacy drug...
Organon (OGN) stock surged approximately 23% on Friday, driven by media reports from India indicating a development with generic drugmaker Sun Pharmaceutical....